MARIMED INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 0.00 shares.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 0.00 shares.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 487.75K shares, a 32.81% increase from fiscal 2022.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 367.25K shares.
- MARIMED INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 460.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 0.00 shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 330.00K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 487.75K shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 330.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-12-31 | -39.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 367.25K shares 10-K · filed 2023-03-03 |
| 2022-09-30 | 181.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2018-12-31 | 60.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-01 | 460.00K shares 10-K · filed 2020-04-01 |
| 2018-09-30 | -300.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-29 |